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The adaptive immune system generates protective
T cell responses via a poorly understood selection
mechanism that favors expansion of clones with
optimal affinity for antigen. Here we showed that
upon T cell activation, the proapoptotic molecule
Noxa (encoded by Pmaip1) and its antagonist Mcl-1
were induced. During an acute immune response
against influenza or ovalbumin, Pmaip1/ effector
T cells displayed decreased antigen affinity and
functionality. Molecular analysis of influenza-specific
T cells revealed persistence of many subdominant
clones in the Pmaip1/ effector pool. When com-
peting for low-affinity antigen, Pmaip1/ TCR trans-
genic T cells had a survival advantage in vitro, result-
ing in increased numbers of effector cells in vivo.
Mcl-1 protein stability was controlled by T cell
receptor (TCR) affinity-dependent interleukin-2
signaling. These results establish a role for apoptosis
early during T cell expansion, based on antigen-
driven competition and survival of the fittest T cells.
INTRODUCTION
Apoptosis plays a central role in T cell immunity by the controlled
elimination of cells during selection in the thymus, contraction of
the effector pool after antigenic clearance, and homeostatic
turnover. Upon antigen encounter, high-affinity T cell clones
are selected and proliferate exponentially from the naive pool.
This crucial step in adaptive immunity has been largely ignored
as a phase where apoptosis might contribute to the outcome.
Until now, only differences in proliferation have been proposed
to be responsible for the dominance of clones with high affinity
in effector T cell populations (Zehn et al., 2009; Malherbe et al.,
2004). Yet, rapid growth creates shifts in selective pressure,
which is a basic biological prerequisite for elimination (Green
and Evan, 2002). Understanding how apoptosis is controlled or
initiated during T cell proliferation would therefore greatly
enhance our knowledge on how antigen-specific effector popu-
lations are formed.754 Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc.Apoptosis as a result of cytotoxic stress is mediated by
the Bcl-2 family of apoptotic molecules, which controls the
integrity of the mitochondrial outer membrane. The Bcl-2 family
comprises both prosurvival proteins like Bcl-2, Bcl-XL, and
Mcl-1 and proapoptotic BH3-only proteins like Bim, Bid,
Puma, Bmf, Noxa, and Bad. These two groups of molecules
antagonize each other to promote or inhibit the activation of
proapoptotic Bax-Bak proteins. Upon activation, Bax and/or
Bak oligomerize in the mitochondrial outer membrane, thereby
generating pores through which factors like cytochrome C are
released. Once in the cytoplasm, cytochrome C can activate
initiator caspase-9, followed by effector caspase activation
and cell death (Youle and Strasser, 2008). The exact molecular
mechanism by which Bax and Bak oligomerization is initiated
by the activity of BH3-only molecules is still under debate
(Merino et al., 2009; Kim et al., 2009). What is clear is that there
is a hierarchy within the BH3-only subfamily in their ability to
promote cell death. Potent apoptosis inducers like Bim, (t)Bid,
and Puma antagonize with distinct affinities all prosurvival
Bcl-2 molecules and directly induce mitochondrial outer
membrane permeabilization after transfection in embryonic
fibroblasts (Willis et al., 2007; Kim et al., 2006; Chen et al.,
2005). Though these three molecules have nonredundant roles
in inducing cell death, only mice deficient for Bim suffer from
clear defects within the lymphocyte compartment under homeo-
static conditions (Bouillet et al., 1999; Jeffers et al., 2003; Yin
et al., 1999; Kaufmann et al., 2009; Erlacher et al., 2006).
However, upon HSV infection, Bim- and Puma-deficient animals
accumulate large numbers of virus-specific CD8+ T cells, which
are greatly impaired in their contraction after viral clearance
(Fischer et al., 2008). Weak inducers of apoptosis, such as
Noxa and Bad, are restricted in their binding of prosurvival
molecules (Kim et al., 2006; Willis et al., 2007) and function as
‘‘sensitizers’’ or ‘‘indirect activators’’ to increase the potency of
Bim, (t)Bid, and Puma (Opferman and Korsmeyer, 2003). Mice
deficient for sensitizers or indirect activators generally lack an
overt phenotype (Villunger et al., 2003; Coultas et al., 2004; Datta
et al., 2002; Labi et al., 2008; Ranger et al., 2003). An unresolved
issue is whether this is due to redundancy or weak activity, or
whether the required conditions for their function have not yet
been uncovered.
Activation and subsequent proliferation of T cells induces
a radical shift in their metabolic requirements. Survival of cells
during this transition is mediated by upregulation of cytokine
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Noxa Sets a Threshold for Optimal T Cell Selectionreceptors, such as the interleukin-2 receptor (IL-2R) and IL-15R
as well as of prosurvival Bcl-2 molecules, such as Bcl-XL. In
addition, the availability of prosurvival cytokines like IL-2 in this
stage can directly influence the equilibrium between pro- and
antiapoptotic Bcl-2 molecules (Bosque et al., 2007). Previously,
we established that naive human T cells after antigen receptor
stimulation in vitro upregulate the proapoptotic sensitizer Noxa
(PMAIP1) (Oda et al., 2000), originally described as a p53-
responsive gene (Villunger et al., 2003) that preferentially inter-
acts with the prosurvival protein Mcl-1 (Kim et al., 2006; Willis
et al., 2007; Chen et al., 2005). Noxa gene targeting provided
a survival advantage for primary and leukemic T cells under
conditions of competition for nutrients (Alves et al., 2006).
We have suggested a role for the Noxa-Mcl-1 axis during expo-
nential growth shortly after T cell activation when availability of
nutrients and cytokines may be limiting among lymphocytes
competing for immunological space (Alves et al., 2007).
Here, we have elucidated the role of Noxa (encoded by
Pmaip1) in in vitro and in vivo models for T cell activation. The
timing of Noxa expression after T cell stimulation correlated
with changes in association betweenMcl-1 and Bim. Upon acute
infection, Pmaip1/ mice showed persistence of subdominant
T cell clones, resulting in amore clonally diverse and less efficient
effector Tcell population. In amodel for polyclonal, T cell receptor
(TCR)-affinity-dependent T cell activation, Noxa-deficient T cells
generated a larger effector cell response. Upon adoptive transfer
into wild-type (WT) mice, Noxa-deficient TCR-transgenic T cells
expanded more effectively after low-affinity triggering. In vitro,
antigen affinity determined the expression of the IL-2 receptor,
and IL-2 signals controlled the stability of Mcl-1, thus providing
high-affinity T cells with a survival advantage. Thus, our results
identify apoptosis, mediated by the dynamic balance between
Mcl-1, Bim, and Noxa, as a key mechanism for the selection of
high-affinity T cells during clonal expansion.
RESULTS
TCR Ligation Shifts the Equilibrium betweenMcl-1, Bim,
and Noxa
We screened 40 apoptosis genes for differential regulation after
T cell activation by multiplex ligation-dependent probe amplifi-
cation RT-MLPA (Eldering et al., 2003), via a newly developed
murine probe set. Murine CD8+ T cells were stimulated in vitro
with CD3 mAbs alone or combined with CD28 costimulation to
specify the effects of TCR ligation and costimulation. No major
differences in transcriptional regulation were observed for these
genes between cells with or without CD28 costimulation. Direct
targets of nuclear factor kappa-light-chain-enhancer of acti-
vated B cells (NF-kB) (Lee et al., 2002), such as the prosurvival
molecules Bcl-XL and A1, were rapidly induced after activation
(Figure 1A; Figures S1A and S1B available online). Analogous
to the human situation, of the BH3-only molecules only Noxa
transcripts were increased persistently. In p53/ cells Noxa
was upregulated after TCR stimulation, but not g-irradiation
(Figure 1B and data not shown), demonstrating that also in
mice Noxa transcription after TCR stimulation is independent
of p53.
Prosurvival Mcl-1, a major binding partner for Noxa, is most
notably regulated on a posttranslational level (Maurer et al.,2006; Zhong et al., 2005) and its degradation is instigated after
binding to Noxa (Czabotar et al., 2007; Dzhagalov et al., 2008).
Mcl-1 mRNA amount was not greatly affected by T cell activa-
tion. On a protein level, however, stabilization of Mcl-1 occurred
rapidly after TCR triggering, as previously reported (Dzhagalov
et al., 2008). Three to five days after T cell activation, Mcl-1
protein gradually decreased (Figure 1C; Figure S1C), which coin-
cided with Noxa induction on day 3 after activation.
Previously it has been shown that Noxa and Bim can compete
for binding to Mcl-1 (Kim et al., 2006). Upregulation of Noxa in
activated T cells may therefore result in a reduced amount of
Bim bound to Mcl-1. Because antibodies against murine Noxa
are not available, interactions of Mcl-1 and Noxa cannot be
studied directly. Therefore, interactions between Mcl-1 and
Bim were compared in wild-type and Noxa-deficient cells in a
semiquantitative fashion by coimmunoprecipitation after T cell
activation. Noxa-deficient cells responded similarly to in vitro
CD3 stimulation as wild-type cells and showed no difference in
proliferation speed (data not shown). Clearly, Bim became disso-
ciated from Mcl-1 after T cell activation in wild-type cells
(Figure 1D), again coinciding with transcriptional upregulation
of Noxa. Moreover, activated T cells from Noxa-deficient mice
showed prolonged association of Mcl-1 and Bim at day 3,
implying that Noxa is involved in displacement of Bim from
Mcl-1 under these conditions.
Noxa Ablation Increases Memory Cell Accumulation
and Naive T Cell Depletion
The differential regulation of Noxa upon in vitro T cell activation
and its suggested role in Bim displacement from Mcl-1 promp-
ted us to reinvestigate the T cell compartment of Noxa-deficient
mice. These animals reportedly lack an overt phenotype under
homeostatic conditions (Villunger et al., 2003), and extensive
analysis of T cell subsets indeed revealed no phenotypic or
functional abnormalities in any of the lymphoid organs of young
(8–12 weeks) Noxa-deficient mice (Figures 2A and 2B; Figures
S2A–S2F).
Aging induces a gradual increase of the effector memory pop-
ulation, which is predominantly caused by antigen exposure
(Lerner et al., 1989). Because Noxa is induced upon T cell activa-
tion, repetitive cycles of this process in vivo might affect the
memory T cell compartment in aged (R18 months) Noxa-defi-
cient mice. Clearly, in all investigated lymphoid organs, aged
Noxa-deficient mice displayed an increase of the effector
memory T cell population, while the naive T cell pool was
concomitantly diminished, most prominently within the CD8+
T cell compartment (Figures 2C and 2D; Figures S2G–S2I). The
central memory population did not appear to be altered in these
mice and no indication for autoreactivity was found by histolog-
ical examination (data not shown). These data suggested that
prolonged and repeated exposure of Noxa-deficient mice to
environmental antigens results in augmented recruitment of cells
from the naive compartment, leading to effector memory cell
accumulation and increased depletion of naive cells.
Ablation of Noxa Affects the Formation of an Oligoclonal
Effector T Cell Population
To investigate whether the observed effector memory cell accu-
mulation in aged Noxa-deficient mice may indeed be caused byImmunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc. 755
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Figure 1. T Cell Activation Leads to a Re-
newed Balance of Bcl-2 Molecules
(A) Expression profiling by RT-MLPA of purified
mouse CD8+ T cells after TCR stimulation. Cells
were stimulated with solid-phase anti-CD3 alone
or in combination with soluble anti-CD28. Gene
induction of pro- and antiapoptotic molecules is
represented in a heat-map after log transformation
of expression levels (scale is from 3.0 to 3.0),
relative to averaged values of unstimulated cells
at day 0 (n = 3).
(B) Differential mRNA expression of selected
apoptosis regulators in wild-type (WT) (black
bars) and p53/ (white bars) CD8+ T cells after
5 days of anti-CD3 stimulation (n = 3). The graph
shows means ± SEM.
(C) (i) RT-PCR analysis for Noxa and 18S ribosomal
RNA of anti-CD3-anti-CD28-stimulated CD8+
T cells. (ii) Immunoblot analysis of total purified
T cells after anti-CD3-anti-CD28 stimulation. A
representative result of three independent experi-
ments is shown.
(D) Immunoprecipitation (IP) of Mcl-1 and immuno-
blot (IB) for Mcl-1 and Bim in total splenocyte
lysates after various days of anti-CD3-anti-CD28
stimulation. For ‘‘day 0’’ samples, twice the
amount of protein input was used to compensate
for low amounts of Mcl-1. Lane marked Ig shows
control IP with an irrelevant antibody. One of three
experiments with comparable results is shown.
Similar findings were obtained with purified T cells.
See also Figure S1.
Immunity
Noxa Sets a Threshold for Optimal T Cell Selectionan altered response of T cells to antigenic challenge, WT and
Noxa-deficient mice were infected with the influenza virus
A/PR8/34. Phenotypically, CD8+ T cell responses appeared
similar between WT and Noxa-deficient mice, but both during
the expansion and contraction phases there was a small but
significant increase in the total number of effector T cells in
Noxa-deficient animals (Figure 3A, top, and data not shown).
Surprisingly, when the antigen-specific population was analyzed
qualitatively by tetramer staining, the fraction of T cells specific
for the dominant epitope Db-NP366-374 was reduced significantly
(Figure 3A, bottom) in Noxa-deficient compared toWTmice. This
population also bound lower amounts of DbNP366-374 tetramers
than WT mice on a per cell basis in all investigated compart-
ments and produced less IFN-g in response to low peptide
concentrations, indicating a reduced TCR affinity and function-756 Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc.ality of the effector cell pool (Figures
3B–3D; Figure S3). Overall TCR expres-
sion was not diminished in Noxa-deficient
mice (Figures S3G and S3H), excluding
this as the cause for the observed
differences.
The effector response against the
influenza NP366-374 epitope is dominated
by one or two high-affinity public Vb8.3+
clones, with characteristic third comple-
mentarity-determining regions (CDR3)
regions (Kedzierska et al., 2006). The
generation of such a highly restrictedresponse suggests a strong selective process during the forma-
tion of the effector T cell population. The influenza model there-
fore provides a unique opportunity to analyze whether the
decreased affinity and function of effector cells in Noxa-deficient
mice corresponds with an altered usage of public Vb8.3+ clono-
types. DbNP366-374-specific CD8
+ T cells were purified at the
peak of the CTL response by FACS sorting via stringent gating,
and clonal expansion within the Vb8.3+ T cells was confirmed
via spectratype analysis (Figure S3I). Strikingly, analysis of the
Db-NP366-374-specific and Vb8.3
+ CD8+ T cell population at the
peak of the CTL response revealed a more diverse set of clono-
types and a smaller contribution of the public dominant clone
in Noxa-deficient mice (Figure 3E), indicating persistence of
subdominant clones. To quantify diversity, the Simpson’s Diver-
sity index (SDI) was used, previously described as the best
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Figure 2. Aged Noxa-Deficient Mice Show
Accumulation of Effector Memory Cells
Wild-type (WT) (black bars) and Noxa-deficient
(white bars) mice were maintained under homeo-
static conditions for 12 weeks (A and B) or 18
months (C and D) and analyzed by flow cytometry.
(A and C) Absolute number of naive (CD44dim
CD62L+), effector memory (CD44+CD62L; EM),
and central memory (CD44+CD62L+; CM) CD8
(top) and CD4 (bottom) T cells in peripheral lymph
nodes (pLN; left) and spleen (right) of young (A)
and aged (C) mice are shown.
(B and D) Representative flow cytometry plots for
CD8+ T cell subsets in the spleens of young (B)
and aged (D) WT and Noxa-deficient mice. The
graphs show means ± SEM. Asterisks denote
significant differences (*p < 0.05, **p < 0.005).
See also Figure S2.
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Noxa Sets a Threshold for Optimal T Cell Selectionmethod to compare the diversity of TCR repertoires (Venturi
et al., 2007). This 0 to 1 scale describes the chance of finding
two different clones when two clones of a single sample are
analyzed, with a value of 1 representing maximum diversity. An
SDI of 0.34 and 0.61 was calculated for WT and Noxa-deficient
clones, respectively, indicating that Noxa-deficient mice
generate a clonally much more diverse effector cell pool upon
influenza infection.
Previously, it has been demonstrated that the affinity of several
of these clones is reduced compared to the dominant clonotype
(Zhong and Reinherz, 2004). The suboptimal response against
a single, well-characterized epitope correlated with increased
pathogenicity as determined by delayed viral clearance and by
slower recovery from bodyweight loss in Noxa-deficient versus
WT mice (Figures 3F and 3G). Thus, it appears that Noxa does
not regulate the maximum overall effector population size but
plays a role in the selective outgrowth of optimal T cell clones
by contributing to apoptosis of subdominant clones.
Differences in viral load may lead to altered T cell responses
(Klenerman and Hill, 2005). To establish the impact of Noxa on
CD8+ T effector cell selection independent of pathogenic load,
we analyzed effector responses in a second acute T cell activa-
tion model, via a pathogen-free immunization strategy. Mice
were immunized via intradermal DNA-tattooing (Bins et al.,
2005) with constructs encoding an ovalbumin-derived peptide
(SIINFEKL) fused to a tetanus toxin fragment. Also in thisImmunity 32, 754–7response, tetramer binding affinity and
the cytokine response upon restimulation
in vitro with OVA-peptides was reduced
in Noxa-deficient compared to WT effec-
tor T cells (Figures 3H–3J). Kb-SIINFEKL-
specific responses are enriched for
Vb5.2-positive cells (Zehn et al., 2009).
Molecular analyses of sorted clones of
wild-type mice revealed that in this case,
TCR diversity within the Vb5.2+ family
(Zehn et al., 2009) of Kb-SIINFEKL-posi-
tive cells was large and not restricted
to one dominant public clone. The de-
creased affinity of Noxa-deficient cloneswas therefore notmanifest against this background of a ‘‘private’’
and already highly diverse (SDI > 0.66) WT TCR repertoire
(Figure S3J). Together these data indicate that the effects
of Noxa depend on affinity of the TCR for MHC-peptide, as
revealed by decreased functionality of effector cells and
increased CDR3 diversity in the sequence space surrounding
dominant clones.No Overt Differences in the Naive T Cell Compartment
between WT and Noxa-Deficient Mice
The observed differences in Noxa-deficient T cell responses
after influenza infection may originate from differences in the
naive T cell repertoire, caused by altered thymic selection.
However, thymocytes and naive T cells from Noxa-deficient
mice were phenotypically and functionally indistinguishable
from their wild-type counterparts (Figure 4A, top and middle).
Apoptosis of CD4-CD8 double-positive (DP) thymocytes as
a result of stimulation with CD3 mAbs in vitro is prevented in
Bim-deficient mice, showing that Bim plays an important role
in negative thymic selection (Bouillet et al., 2002). CD3 anti-
bodies had no influence on survival of CD4-CD8 double-nega-
tive cells, but rapidly induced apoptosis in DP cells (Figure 4A,
bottom). No survival advantage was seen for Noxa-deficient
cells. Expression of Noxa was undetectable in thymocytes, in
contrast to Bim, which is highly expressed in DP cells. TCR65, June 25, 2010 ª2010 Elsevier Inc. 757
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Figure 3. Decreased Antigen Affinity and
Increased TCRDiversity of Antigen-Specific
CD8 T Cells in Noxa-Deficient Mice
(A) Total CD44+CD62L effector (top) and
DbNP366-specific (bottom) CD8+ T cells in the
blood of influenza-infected WT (black squares)
and Noxa-deficient (Pmaip1/, white circles)
mice (n = 8).
(B) Representative FACS plots of CD8+ T cells in
the lung, stained with DbNP366 tetramers.
(C) Quantification of the mean fluorescence inten-
sity (MFI) of DbNP366 binding blood CD8+ T cells
on day 10 p.i.
(D) IFN-g production induced by varying doses of
peptide in NP366-374 restimulated splenic CD8
+
T cells from influenza-infected mice, relative to
the level of cells stimulated with saturating
(500 ng/ml) amounts of peptide on day 10 pi.
(E) Cumulative clonal composition of the
Vb8.3+NP366+ CD8+ T cell population in WT and
Noxa-deficient mice, 10 days p.i. with influenza
virus. Given is the relative contribution of each
clone to the total Vb8.3+NP366+ population (WT
n = 182, Noxa-deficient n = 149 clones sequenced
from 4mice of each), amino acid sequence of CD3
regions is indicated.
(F) Virus titers in influenza-infected WT and Noxa-
deficient mice at separate days (day 7–10) after
infection were measured in the lung (total number
of mRNA copies of the viral M1 matrix gene).
Data shown are representative for two separate
experiments performed with 5–8 mice at each
time point.
(G) Body weight of WT and Noxa-deficient mice
(n = 8) infected with influenza virus, relative to their
weight at the start of the experiment. Shown are
representative data of three independent experi-
ments with comparable results.
(H) Antigen affinity of specific CD8+ T cells in mice
immunized intradermally with a DNA construct
encoding SIINFEKL peptide from ovalbumin
(OVA). Representative FACS plots of CD8+ T cells
in the blood, stained with KbOVA.
(I)Quantification of themeanfluorescence intensity
(MFI) of KbOVA binding CD8+ T cells from the
experiment in (H) on day 12 p.i. (n = 8 for WT and
Noxa-deficient mice).
(J) IL-2 production induced by varying doses of SIINFEKL-stimulated CD8+ T cells from intradermally immunized mice, relative to the level of cells stimulated with
saturating (500 ng/ml) amounts of peptide. n.s. indicates not significant.
Where applicable, error bars indicate SEM. See also Figure S3.
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Noxa Sets a Threshold for Optimal T Cell Selectiontriggering in these cells also did not lead to Noxa induction (data
not shown).
Next, peripheral naive T cells were compared for TCR Vb
usage and CDR3 length distribution. No differences between
WT and Noxa-deficient mice were seen in the amount of naive
(CD44dimCD62L+) CD8 T cells expressing Vb5, Vb6, or Vb8.3
(Figure 4B). Spectratype analysis of flow sorted naive cells
revealed a normal Gaussian distribution with no increase of
exceptionally short or long sequences within the CDR3 regions
of the Vb5.2 and Vb8.3 families of Noxa-deficient mice (Fig-
ure 4C). These findings show that Noxa-deficient mice have
a normal naive T cell repertoire of similar composition as wild-
type mice and suggest that the observed differences in acute
activation models therefore most probably arise after peripheral
activation by antigen.758 Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc.Noxa Ablation Allows Enhanced Expansion of T Cells
upon Low-Affinity Triggering
In order to establish whether the observed differences in clonal
selection were intrinsic to T cells and based on the affinity of
TCR triggering, several approaches were taken. First, we
reasoned that activation independent of TCR affinity should
induce no differences in expansion between WT and Noxa-
deficient mice. In support of this notion, the superantigen
staphylococcal enterotoxin B (SEB), which activates all Vb8+
T cells independent of their antigen specificity (White et al.,
1989), elicited CD4+ and CD8+ T cell responses of similar
magnitude in WT and Noxa-deficient animals (Figures 5A
and 5B).
Second, we investigated whether the observed phenotype
was T cell intrinsic. An adoptive transfer system was used of
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Figure 4. Noxa-Deficient Mice Show No
Signs of Altered Thymic Selection
(A) Absolute numbers of total (top) and CD4CD8
(middle) thymocyte subsets. (Bottom) Thymocytes
were stimulated in vitro with solid-phase aCD3 and
viability was assessed by AnnexinV-To-Pro-3
staining.
(B) Phenotyping of peripheral CD8+ T cells reveals
a normal distribution of TCR Vb usage in Noxa-
deficient mice. Error bars indicate SEM.
(C) Spectratype analysis of naive Vb5.2+ and
Vb8.3+ CD8+ T cells in wild-type and Noxa-defi-
cient mice.
Immunity
Noxa Sets a Threshold for Optimal T Cell Selectionabundant T cell costimulation, in which vast polyclonal T cell
expansion based on antigen recognition occurs. Mice that
constitutively express the TNFRFS7 (CD27) ligand CD70 on B
cells (CD70TG mice) possess an enlarged fraction of effector
T cells, which is dependent on environmental antigen recognition
(van Gisbergen et al., 2009; Tesselaar et al., 2003; Arens et al.,
2001). WT or Noxa-deficient (Ly5.1+) T cells were transferred
into CD27-deficient or CD27-deficient-CD70TG (Ly5.2+) mice.
These recipients have no overt phenotype and only the donor
T cells can respond to the CD70 transgene, because they
express CD27. In this milieu of continuous CD70 costimulation,
transferred T cells underwent rapid expansion, which was signif-
icantly larger after transfer of Noxa-deficient T cells (Figure 5C).
The majority of cells upregulated the effector cell marker KLRG1
(Joshi et al., 2007), indicating that these cells originated from
a recently activated precursor (Figure 5D; Figure S4). At 3 weeks
after transfer, the expanded population had undergone almost
complete contraction, indicating that the antigen-responsive
pool of transferred naive clones, required to supplement and
thus maintain the short-lived effector cell population, had been
depleted. The contraction of donor effector cells occurred with
similar kinetics between wild-type and Noxa-deficient cells, sug-
gesting that this phase is independent of Noxa in this model.
Third, to gather formal proof that Noxa ablation provides an
in vivo advantage over Noxa-sufficient cells in a TCR affinity-
dependent fashion, Noxa-deficient mice were crossed with
OT-I TCR transgenic mice. Low amounts of purified CD8+Immunity 32, 754–7T cells from these Noxa-deficient/OT-I
(termed NoxOTI here) mice or from con-
ventional OT-I mice (both Ly5.2+) were
transferred to WT recipients (Ly5.1+)
to provide sufficient competition of the
transferred cells with the host response
after immune activation. One day after
transfer, micewere infectedwith a Listeria
monocytogenes strain expressing the
high-affinity peptide SIINFEKL (LN4) or
the low-affinity peptide SIITFEKL (LT4)
(Zehn et al., 2009), and T cell responses
were followed in the blood. For mice
infected with LN4, there was no signifi-
cant difference betweenOT-I and NoxOTI
T cells, which both expanded to approxi-
mately 40% of total effector cells at thepeak of the response (Figure 5E). As expected (Zehn et al.,
2009), infection with LT4 provided a highly reduced response,
which reached its maximum 1 day earlier. Significantly, trans-
ferred NoxOTI cells showed a response that expanded up to
four times the amount of transferred OT-I cells (Figure 5E).
Representative FACS staining and additional data from two
separate transfer experiments is shown in Figure 5F and Figures
S4B and S4C.
Combined, these transfer experiments indicate that specifi-
cally after low-affinity TCR stimulation, Noxa ablation provides
an intrinsic selective advantage for expanding T cells in vivo.
Affinity of TCR Ligation Controls Mcl-1 Stability
The involvement of Noxa in formation of high-affinity effector
populations implies that the affinity of the TCR-ligand interaction
influences the balance between Noxa and its binding partners.
To test this directly, the effect of TCR binding affinity on the
regulation of Bcl-2 members on a transcriptional and posttrans-
lational level was investigated. OT-I transgenic T cells were
stimulated in vitro for 5 days with high- (SIINFEKL; N4), interme-
diate- (SAINFEKL; A2), or low- (SIITFEKL; T4, SIIQFEKL, Q4)
affinity peptides (Zehn et al., 2009). No differences in the tran-
scriptional regulation of the Bcl-2 molecules, including Mcl-1,
A1, Bim, and Noxa, was observed between cells stimulated
with N4 or A2. However, on a protein level, after the initial induc-
tion (see also Figure 1C), Mcl-1 declined more rapidly under
conditions of suboptimal stimulation, whereas amounts of Bim65, June 25, 2010 ª2010 Elsevier Inc. 759
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Figure 5. Noxa Ablation Provides a T Cell-
Intrinsic, TCR-Affinity-Dependent Competi-
tive Survival Advantage for Low-Affinity
T Cells
(A and B) Mice were injected intraperitoneally with
20 mg staphylococcal enterotoxin B (SEB) and
Vb8-positive T cell responses were analyzed by
flow cytometry.
(A) Relative increase of CD4+ (left) and CD8+ (right)
effector cells within the Vb8-positive fractions.
(B) Relative number of Vb8-positive CD4+ (left) and
CD8+ (right) T cells as a fraction of total CD4+ and
CD8+ cells, respectively.
(C and D) Increased expansion of Noxa-deficient
donor cells after transfer to a CD70TG host.
(C) WT (Wt/) and Noxa-deficient (Pmaip1//)
T cells (Ly5.1+) were adoptively transferred in
CD27-deficient (TNFRSF7/)or CD27-deficient-
CD70TG recipient mice (Ly5.2+). Shown is the
increaseofdonorCD8+Tcells in thebloodasa frac-
tion of the total number of CD8+ T cells, relative to
day 1 (n = 5). Statistical differences are compared
to WT cells transferred to CD27-deficient recipi-
ents, unless indicated otherwise.
(D) Phenotypic analysis of adoptively transferred
cells by KLRG1 staining. Cells were gated for
CD8+ T cells.
(E and F) OT-I and NoxOTI T cells (Ly5.2+) were
adoptively transferred in wild-type recipient mice
(Ly5.1+). One day after transfer, recipient mice
were infected with Listeria SIINFEKL (LN4; n = 3)
or with Listeria SIITFEKL (LT4; n = 5). One mouse
transferred with OT-I T cells was poorly infected
with LN4 and was excluded from the analysis.
(E) Shown is the number of donor cells as a fraction
of the total CD8 T cell pool.
(F) Representative FACS plots of total white blood
cells 6 days after infection.
See also Figure S4 where data from a replicate
experiment are shown. Where applicable, error
bars indicate SEM.
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Noxa Sets a Threshold for Optimal T Cell SelectionandBcl-XL remained constant (Figure 6A; Figure S5C). No signif-
icant differences in proliferation were observed between N4 and
A2 peptides. In contrast, stimulation with lower-affinity peptide
resulted in a lower induction of CD25, the a chain of the IL-2
receptor (Figure 6B). IL-2 and IL-15 share the usage of their
b-chain and of the common g chain (gc), and signaling through
gc receptors has previously been associated with Mcl-1 stability
as well as with Bim- and Noxa-mediated survival (Bosque et al.,
2007; Huntington et al., 2007). CD25 expression was clearly
associated with the dose and affinity of peptides used to stimu-
late OT-I T cells (Figure S5B). To establish whether IL-2 signaling
regulated Mcl-1 expression, OT-I T cells were stimulated in vitro
with limiting N4 or T4 peptide in the presence or absence of
exogenous IL-2. Low-dose T4 stimulation provided poor T cell
activation with significantly less CD25 expression than after N4
stimulation. T4 stimulation in the presence of exogenous IL-2,
on the other hand, boosted CD25 expression to the level
observed after N4 stimulation alone (Figures 6C–6I). Addition
of 10 ng/ml IL-2 alone did not induce T cell activation or CD25
expression. Western blot analysis revealed that Mcl-1 amounts
correlated strongly with CD25 expression (Figure 6C, part ii),
suggesting that TCR affinity mediates cellular survival indirectly760 Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc.via differential IL-2R signaling and regulation of the Noxa-
Mcl-1 axis.
Based on the previous data, we hypothesized that in NoxOTI
cells Mcl-1 would remain higher after low-affinity TCR stimula-
tion and that this would provide a survival advantage over OT-I
cells. Indeed, NoxOTI cells displayed increased amount of
Mcl-1 compared toOTI cells after T4 peptide stimulation (Figures
S5D and S5E). To test survival under competitive conditions,
CD8+ T cells were purified from OT-I and NoxOTI mice, mixed
in a 1:1 ratio, labeled with carboxyfluorescein diacetate succini-
midyl ester (CFSE), and stimulated with OVA peptides of
decreasing affinity. The ratio of NoxOTI versus OT-I cells was
followed over time within the viable (AnnexinV-PI) population.
Fluorescent labeling was used to distinguish between the two
populations (see Experimental Procedures), which was possible
up to 3 days after stimulation (Figure S5F). Noxa ablation
provided no advantage for cells stimulated with N4 peptides,
but when peptides of reduced affinity were used, NoxOTI cells
survived better, most prominently within the dividing fraction
(Figure 6D). Moreover, when exogenous IL-2 was added, this
survival advantage was abolished because of enhanced survival
of dividing OT-I cells. Together, these data indicate that TCR
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Figure 6. TCR Affinity Specifically Controls Mcl-1 Protein Amount via Differential IL-2R Signaling
(A and B) Purified splenic OT-1 transgenic T cells were stimulated with 10 ng/ml high-affinity SIINFEKL (N4) or low-affinity SAINFEKL (A2) peptides as indicated.
(A) Immunoblot for apoptotic molecules on designated days for N4 or A2 stimulation. Shown is one of six independent experiments with similar results.
(B) Representative histograms for cells labeled with CFSE and stained with anti-CD25. Shown is one of six independent experiments.
(C) Purified splenic OT-1 transgenic T cells were stimulated with 10 ng/ml IL-2, with 0.1 ng/ml high-affinity SIINFEKL (N4), or low-affinity SIITFEKL (T4) peptides or
with a combination, as indicated. (i) Representative plots of CD25 expression. (ii) Mcl-1 expression as determined by western blot.
(D) Purified OT-I or NoxOTI cells were DDAO labeled before being mixed in a 1:1 ratio. Subsequently thesemixed cultures were CFSE labeled and stimulated with
altered peptide ligands in the absence or presence of exogenous IL-2. (i) NoxOTI/OTI ratio was determined within the AnnexinV-PI population. Stars indicate
significant differences compared to N4-stimulated cells. n.s. = not significant. Shown are the combined results of three independent experiments, with two mice
of each genotype per experiment (n = 6). Error bars indicate SEM. (ii) Representative CFSE plots show primarily differences within the divided population.
See also Figure S5.
Immunity
Noxa Sets a Threshold for Optimal T Cell Selectionaffinity mediates activated T cell survival via differential regula-
tion of IL-2R signaling and indirect modulation of the Noxa-
Mcl-1 axis.
DISCUSSION
Based on our data, we propose that apoptosis plays an integral
role in the formation of effector populations by setting boundaries
for expansion during the initial phase after T cell activation. On
a molecular level, our primary findings are that proapoptotic
Noxa is transcriptionally upregulated after a delay upon TCR
triggering and that Mcl-1 is rapidly stabilized on a protein level in
aTCRaffinity-dependent fashion, involvingan IL-2-IL-2Rsignaling
loop. On a physiological level, we linked these molecular findings
to the formation of high-affinity effector cells upon immune activa-
tion by elimination of subdominant clones of low affinity.
Mcl-1 protein is subject to complex regulation by phosphory-
lation, and binding of Noxa has also been directly implicated in
mediating its stability (Czabotar et al., 2007; Dzhagalov et al.,
2008). In addition, binding of Noxa has been shown to result in
competition with Bim for binding places on Mcl-1 (Kim et al.,
2006). Importantly, this latter mechanism may also hold for A1,the other binding partner of Noxa (Chen et al., 2005), which is
also induced upon TCR triggering. Enhanced expression of
Noxa would displace Bim, and free Bim is then able to antago-
nize other prosurvival molecules such as Bcl-XL, or may directly
bind Bax to induce apoptosis. The dynamic balance between
Noxa, Bim, and Mcl-1 may thus set a threshold for survival of
high-affinity clones in the competitive niche occupied bymultiple
expanding T cell clones. Lowering of this threshold via ablation of
Noxa directly affects the size and quality of effector T cell
responses in vivo. Activation of T cells thus appears to induce
a molecular process that protects cells from apoptosis in the
initial stages by upregulation of prosurvival Bcl-2 molecules,
but later on sensitizes them to proapoptotic stimuli via induction
of Noxa.
A prominent candidate for such a stimulus is deprivation of the
cytokine IL-2, a member of the gc-cytokines linked both to prolif-
eration and survival via the Jak-Stat, MAPK, and PI3K signaling
pathways (Benczik andGaffen, 2004).Mcl-1, aswell as its antag-
onists Bim and Noxa, have been associated with apoptosis as
a result of gc-cytokine deprivation (Bosque et al., 2007; Hunting-
ton et al., 2007, 2009). Experiments with growth factor-depen-
dent cell lines show that under limiting cytokine concentrations,Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc. 761
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Noxa Sets a Threshold for Optimal T Cell Selectionphosphatidylinositol-3-kinase activity is reduced, which leads to
glycogen synthase kinase 3 beta-dependent Mcl-1 phosphory-
lation, ultimately resulting in its proteasomal degradation (Maurer
et al., 2006; Morel et al., 2009). In CD8+ T cells, Mcl-1 levels are
especially sensitive to deprivation of IL-2 (Bosque et al., 2007).
Moreover, a recent report showed that TCR triggering with
reduced affinity does not affect early replication of OT-1 cells
in vivo (Zehn et al., 2009), but leads to reduced expression of
the receptors for IL-2 and the chemokine receptor CCR7. Our
study agrees well with those findings and provides a new link,
apart from proliferative differences, between low-affinity trig-
gering and reduced expansion. We propose that in a normal
setting, low-affinity clones will exit the lymph node supposedly
as a result of reduced CCR7 expression, and in the periphery
through lack of IL-2 signaling undergo apoptosis via the Noxa-
Bim-Mcl-1 axis. An essential component of this scheme is
competition between many highly similar T cell clones present
in equal amounts in the naive pool (Nikolich-Zugich
et al., 2004). Of note, this competitive aspect is lacking in trans-
genic models we and others used with a single or a limited set of
TCRs (Zehn et al., 2009; Malherbe et al., 2004), where the
variation in affinity is instead modeled by applying distinct anti-
genic peptides. Still, the molecular pathways involved can be
expected to be similar and point to a controlling role of IL-2
signaling after low-affinity TCR triggers.
Interestingly, two recent papers describe differences in IL-2R
signaling strength as a determining factor for the formation of
memory or effector T cells by differential regulation of key tran-
scription factors (Pipkin et al., 2010; Kalia et al., 2010). In these
studies, high-affinity TCR triggering was used and differences
in CD25 expression occurred several days after activation. Since
we found that differences in TCR ligation strength influence
CD25 levels rapidly after activation, this appears to be a different
mechanism, regulated primarily on a protein level, which pre-
cedes the choice via transcription factors of memory or effector
cell formation.
In summary, TCR affinity controls the amount of Mcl-1 via IL-2
signaling, and Noxa functions to augment the threshold for
survival of activated T cells. Although on a single-cell level this
has a binary outcome (alive or dead), on a population level it
will prevent the persistence of less useful clones that compete
with high-affinity clones for limited resources during the expan-
sion phase of activated T cells. Thus, unhindered proliferation
and survival of the ‘‘fittest’’ (i.e., those with the best fit on their
MHC-peptide ligand) clones is safeguarded via a Darwinistic
selection process.
Studies into the role of Bcl-2 proteins in acute infections
have focused mostly on the contraction of effector cell popula-
tions after clearance of the pathogen (Fischer et al., 2008; Pelle-
grini et al., 2003). A strong inducer of apoptosis like Bim is
expressed in all T cell subsets from the double-positive thymo-
cyte subset onward. Bim-deficient mice therefore show a
profound phenotype during both homeostasis and contraction.
Noxa is expressed at very low levels in naive T cells but is
strongly induced upon activation of these cells, hence our obser-
vation that this proapoptotic molecule plays a role only during
this phase of T cell biology. Considering this notion, it might
therefore be predicted that deficiency of Bim, which remains
expressed after T cell activation, will also result in increased762 Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc.diversity within the antigen-specific population upon acute infec-
tion. A complicating factor in the analysis of these mice is their
reduced thymic selection, which results in a naive compartment
of already increased diversity (Bouillet et al., 2002; Malherbe
et al., 2004). It has to be noted that it cannot be formally excluded
that Noxa-deficient mice on a clonal level have a naive compart-
ment of increased diversity compared to wild-type mice.
However, normal thymic cell numbers and phenotypic composi-
tion in Noxa-deficient animals, lack of Noxa expression in
double-positive thymocyte subsets, lack of a survival advantage
for anti-CD3-stimulatedNoxa-deficient DP thymocytes, a normal
TCR Vb usage of their peripheral T cells, and a lack of auto-
immunity in aged Noxa-deficient mice indicate that this is
unlikely. Lastly, the effects of Noxa ablation were maintained in
TCR transgenic OT-I mice, again arguing that they occur after
thymic selection.
The formation of specific effector cell responses against
pathogens must be broad, in the sense that many epitopes are
recognized to generate an optimal response, as well as specific
to ensure that only a response against relevant epitopes is
formed. We argue that these conditions require that on a per
epitope basis, only high-affinity cells are allowed to survive and
mount a response. This aspect adds an additional layer of regu-
lation to the formation of effector cell responses and may have
implications for immunocompromised patients. An inability to
form an effective T cell response might result not only from
poor T cell activation, but also from impaired selective pressure.
Modern therapeutic techniques, such as in vitro administration of
costimulatory molecules to boost T cell responses, might there-
fore be counterproductive without simultaneous attempts to
increase specificity of the response. Our preliminary data indi-
cate that Noxa ablation actually induces organ pathology as
a result of a specific effector cell accumulation (unpublished
data). Our findings therefore have implications for the under-
standing of viral disease progression, the design of vaccination
strategies, and antiviral drug development. Finally, based on
the depletion of the naive compartment in aged Noxa-deficient
mice, it can be envisaged that also memory formation and/or
function is affected by impaired initial T cell selection.
In conclusion, deficiency of proapoptotic Noxa leads to
persistence of suboptimal T cell clones, causing the generation
of a less efficient effector population in acute responses and
resulting in effector memory cell accumulation in aged mice.
These findings show that apoptosis during the expansion phase
is crucial for shaping adaptive immune responses, with implica-
tions for acute and chronic infections, as well as aging of the
immune system.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6), OT-1, and B6 Ly5.1+ JAX mice were purchased from Charles
River and kept as breeding colonies in our local animal facility. Only these
mice, which were kept under identical conditions as our transgenic and
gene-ablated mice, were used as WT controls in our experiments. Noxa-defi-
cientmicewere a kind gift fromA. Strasser (WEHI, Melbourne) and provided by
M. Serrano (CNIO, Madrid). Noxa5.1 mice were generated by crossing Noxa-
deficient mice with B6 Ly5.1+ mice from our in house colony. NoxOTI mice
were generated by crossing Noxa-deficient mice with B6 OT-1 mice from
our in-house colony. p53/ tissues were a gift from M. Breuer (NKI,
Immunity
Noxa Sets a Threshold for Optimal T Cell SelectionAmsterdam). TNFRFS7-deficient, B cell-specific CD70TG and TNFRFS7-defi-
cient CD70TG mice were generated as previously described (Hendriks et al.,
2000; Arens et al., 2001; van Gisbergen et al., 2009). Mice were used at
6–12 weeks of age, unless stated otherwise, age- and sex-matched within
experiments, and were handled in accordance with institutional and national
guidelines. All experiments were performed according to protocols approved
by our institutional ethical committee. Apart from the p53/mice (BALB/c), all
mice were either generated in B6mice or backcrossed at least 10 times on this
background.
Flow Cytometry
Single-cell suspensions were obtained by mincing the specified organs
through 40 mm cell strainers (Becton Dickinson). Erythrocytes were lysed
with an ammonium chloride solution (155 mM NH4Cl, 10 mM KHCO3, and
1 mM EDTA) and cells were subsequently counted with an automated cell
counter (SCHA¨RFE SYSTEM). Cells (5 3 105–5 3 106) were collected in
staining buffer (PBS with 0.5% bovine serum albumin [Sigma]) and stained
for 30 min at 4C with antibodies in the presence of anti-CD16/CD32 (clone
2.4G2, anti-mouse FcgRII-RIII (a kind gift of L. Boon, Bioceros, Utrecht, the
Netherlands). For a list of themonoclonal antibodies used see Table S1. Conju-
gated DbNP366 and KbOVA tetramers were obtained from Sanquin (http://
www.sanquin.nl). FACS experiments were performed on a FACSCalibur or
FACSCanto (Becton Dickinson) and analyzed with FlowJo software (TriStar).
Cell viability was assessed by staining with FITC conjugated AnnexinV (BD
bBiosciences) followed by adding 100 nM To-Pro-3 (Molecular Probes) shortly
before measurement. Naive (CD3+CD4CD8+CD44CD62L+DbNP366) and
NP366-specific (CD3+CD4CD8+DbNP366+) CTLs were sorted to >99%purity
with a FACSAria (Becton Dickinson).
Cell Culture
Spleen-derived T cells were purified to >95% purity by positive or negative
selection with the MACS cell separation system (Myltenyi). CD8+ T cells
were positively selected with anti-CD8 microbeads (Myltenyi). Cells were
stimulated in RPMI medium with 10% fetal calf serum (FCS) with solid phase
anti-CD3 (145-2C11) alone, in combination with soluble anti-CD28 (37.51)
(both a kind gift of L. Boon). DNA-damage-mediated apoptosis was induced
by 2.5 Gy g-irradiation, with a 137CS-source. Purified OT-I T cells were
stimulated in vitro with 0.1, 1, or 10 ng/ml SIINFEKL (N4), SAINFEKL (A2),
SIITFEKL (T4), or SIIQFEKL (Q4) peptides. Where indicated, 10 ng/ml IL-2
(R&D Research) was added. Cell division was analyzed by carboxyfluorescein
diacetate succinimidyl ester (CFSE, Molecular Probes) dilution. In mixed colo-
nies, OT-I or NoxOTI cells were labeled with 7-hydroxy-9H(I,3)-dichloro-9,
9-dimethylacridin-2-one succinimidyl ester (DDAO-SE, Molecular Probes) to
distinguish between populations. Activation status of T cell subsets was
analyzed by anti-CD69 and anti-CD25 or CD44 and CD62L staining.
RT-MLPA Analysis
Total RNA for reverse transcriptase multiplex ligation-dependent probe ampli-
fication (RT-MLPA) was extracted via the trizol isolation method (Invitrogen).
mRNA amounts were analyzed with the Apoptosis Mouse RT-MLPA kit
RM002 (MRC-Holland, http://www.mlpa.com) according to themanufacturer’s
instructions. Samples were run through a Genescan and analyzed with Gene-
Mapper (Applied Biosystems GmbH; http://www.appliedbiosystems.com)
and subsequently with Excel software (Microsoft), as described previously
(Eldering et al., 2003; Alves et al., 2006).
Influenza Infection, DNA-Tattooing, SEB, Adoptive Transfer,
and Listeria Infection
Influenza A virus of the A/PR8/34 strain (H1N1) was generated in LLC-MK2
cells and TCID50 was determined in wild-type B6 mice. Mice were infected
intranasally with 10 3 TCID50. Virus titers were determined by quantitative
polmerase chain reaction (qPCR) as described (Dessing et al., 2007), with
the primers 50-GGACTGCAGCGTAGACGCTT-30 (forward), 50-CATCCTGTT
GTATATGAGGCCCAT-30 (reverse), 50-CTCAGTTATTCTGCTGGTGCACTTG
CC-30 (50-FAM labeled probe). DNA-Tattooing was performed basically
as described (Bins et al., 2005). In brief, 30 mg of d1TTFC-SIINFEKL
DNA-constructs were applied on the skin of the hind leg after hair removal
with depilatory cream (VEET, ReckittBenckiser), and administeredwith Perma-nent Make Up tattoo machine (MT Derm GmbH, Berlin, Germany). Tattooing
was performed with a disposable 9 needle bar oscilating at 100HZ for 30 s
at a depth of 1mm, and the procedure was repeated twice with 2 day intervals.
Staphylococcal enterotoxin B (Sigma) was dissolved in PBS and 20 mg per
mouse was injected intraperitonal. For adoptive transfer to study polyclonal
responses, total T cells of WT and Noxa-deficient mice (both Ly5.1+) were iso-
lated from spleens by positive selection for CD4+ and CD8+ T cells with the
MACS cell separation system (Myltenyi). Cells were injected intravenous in
TNFRFS7-deficient and TNFRFS7-deficient-CD70TGmice. After 24 hr, transfer
efficiency was determined by FACS. For adoptive transfer to studymonoclonal
responses, CD8+ T cells of OT-I and NoxOTI mice (both Ly5.2+) were isolated
from spleens by positive selection for CD4+ and CD8+ with the MACS cell
separation system (Myltenyi). 5000 cells per mouse were injected intrave-
nously in wild-type (Ly5.1+) recipients. Infection with a Listeria monocytogenes
strain expressing the SIINFEKL (N4) or SIITFEKL (T4) sequence (Zehn et al.,
2009) occurred intravenously at 2500 colony forming units (CFU), 1 day after
transfer of cells.
Immunoprecipitation, Immunoblot, RT-PCR, and Histochemistry
For immunoprecipitation cells were lysed in a 1% Triton X-100-containing lysis
buffer at the indicated time points after aCD3-aCD28 stimulation. Cell lysates
were precleared with normal rabbit serum coupled to protein A-sepharose
(Sigma) followed by an immunoprecipitation with Mcl-1 antibody coupled to
protein A-sepharose. Beads were pelleted, washed 6 times, and boiled in
sample buffer for western blot analysis, by means of the Bio-Rad mini-
PROTEAN electrophoresis system as described (Alves et al., 2006), with
primary antibodies against b-Actin (Santa Cruz Biotechnology), Bim (Stress-
gen), Bcl-XL (Transduction Laboratories), and Mcl-1 (Rockland). Staining
was visualized with IRDye 680 or 800 labeled secondary antibodies and an
Odyssey Imager (Li-Cor). Quantification of signal was performed with Odyssey
3.0 software. Total RNA was extracted with the Trizol isolation method (Invitro-
gen) and cDNAwas generated with oligodeoxythymidine (oligo dT) and Super-
script II Reverse Transcriptase (Invitrogen). Noxa transcripts were amplified by
polymerase chain reaction (PCR) with Noxa sense and antisense primers
(50-CTCTCGAGCCCGGGAGAAAGGCGC-30 and 50-GGGAATTCTCAGGTTA
CTAAATTGAAGAGCT-30 ) and 18S was used as a loading control (50-TCAA
GAACGAAAGTCGGAGG-30 and 50-GGACATCTAAGGGCATCACA-30). For
histochemistry, formaldehyde-fixed tissues were imbedded in paraffin. For
histochemcal analysis, sections were stained with hematoxylin and eosin.
Intracellular Cytokine Staining
To determine direct ex vivo cytokine production, splenocytes were plated
at 1 3 106 cells/well in a 96-well round-bottom plate and stimulated with
10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 1 mM ionomycin (Sigma)
or with increasing concentrations of peptide (ASNENMDAM or SIINFEKL;
Genscript, http://www.genscript.com) for 6 hr at 37C. During the final 4 hr,
1 mg/ml of the protein-secretion inhibitor Brefeldin A (Sigma) was added.
Thereafter, cells were washed and stained with anti-CD4 or anti-CD8, followed
by fixation and permeabilization (Becton Dickinson). Cells were then incubated
for 30 min with fluorescently labeled antibodies against IFN-g, TNF-a, IL-2,
IL-10, or IL-17, thoroughly washed, and analyzed by flow cytometry.
PCR Analysis of TCR Clones
Cells were sorted on day 9 and 10 after infection and cDNA was generated
from mRNA after extraction with the Trizol isolation method. TCR Vb-Cb
elements were amplified by PCR, with the Vb5.2 primer (50-AAGGTGGAGA
GAGACAAAGGATTC-30) or the Vb8.3 primer (50-TGCTGGCAACCTTCGAA
TAGGA-30) in combination with a FAM-labeled Cb1 primer (50-CTTGGGTG
GAGTCACATTTCTC-30). Productswere run through aGenescan and analyzed
with GeneMapper (ABI) for spectratyping. Simultaneously, the PCR product
was cloned in pGEM-T (Promega) and colonies positive for the Vb5.2 or
8.3 gene element were sequenced. Sequence reactions were performed
with the Big Dye Terminator kit (Applied Biosystems) and sequence analysis
was executed by an in-house facility. The sequences were analyzed
online, with the International ImMunoGeneTics information system (IMGT)
(http://imgt.cines.fr). Clones containing two or more basepair differences
with all other clones were defined as unique.Immunity 32, 754–765, June 25, 2010 ª2010 Elsevier Inc. 763
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Statistical analysis of the data was performed with the unpaired Student’s
t test, Wilcoxon rank-sum test, or one-way ANOVA test where applicable.
Asterisks denote significant differences (*p < 0.05, **p < 0.005, ***p < 0.0005).
SUPPLEMENTAL INFORMATION
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